Trials
Search / Trial NCT05641402

Evidence-based Text Messages to Target Diet and Physical Activity

Launched by UNIVERSITY OF MANCHESTER · Nov 30, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

ClinConnect Summary

This clinical trial is looking to create helpful text messages to support people with type 2 diabetes in making better choices about their diet and physical activity. The goal is to develop messages that encourage positive changes in these areas, which can be very important for managing diabetes effectively. The trial is currently recruiting participants, including both experts in behavior change and individuals with type 2 diabetes.

To be eligible for the study, participants should be at least 18 years old, have a diagnosis of type 2 diabetes, and have access to a mobile phone they can use to send and receive messages. Participants will help by sharing their experiences and providing feedback on the text messages created. It's important to note that certain individuals, such as those who have recently been hospitalized for diabetes-related issues or are pregnant, will not be eligible to participate. Overall, this trial aims to find new ways to support people living with diabetes through everyday technology.

Gender

ALL

Eligibility criteria

  • For the expert workshop -
  • Inclusion criteria: researchers with expertise in behaviour change, physical activity, diet and/or diabetes
  • - For focus group
  • Inclusion criteria
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or female, aged 18 years or above.
  • A diagnosis of type 2 diabetes.
  • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
  • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages or messaging within smartphone applications).
  • Exclusion criteria
  • Moved out of England prior to taking part in the study
  • For the anticipated acceptability survey and experienced acceptability study
  • Inclusion criteria
  • Participant is willing and able to give informed consent for participation in the study.
  • Aged 18 years or above.
  • A diagnosis of type 2 diabetes.
  • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
  • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages).
  • Exclusion criteria
  • Within three months of a hospital admission for hyperglycaemia or hypoglycaemia.
  • Pregnant or within three months post-partum by self-report
  • Underweight (For anticipated acceptability this will be by self-report, for experienced acceptability BMI\<18.5)
  • Historical or current diagnosis of an eating disorder Prescribed insulin for their diabetes

Trial Officials

Kiera Bartlett, PhD

Principal Investigator

University of Manchester

About University Of Manchester

The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.

Locations

Manchester, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials